Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | PYCR1 | P32322 | 4/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29923478 | 0.90 | TAAR1 (0.40) | TAAR1KDM4EALDH1A1PYCR1CHRNA7 | |
| Bromide SCHEMBL17180522 | 0.88 | TAAR1 (0.39) | TAAR1KDM4EALDH1A1PYCR1CHRNA7 | |
| SCHEMBL14948386 | 0.82 | KDM4E (0.43) | TAAR1KDM4EALDH1A1PYCR1MAPT | |
| SCHEMBL14948315 | 0.82 | ALDH1A1 (0.38) | TAAR1KDM4EALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL14948388 | 0.82 | ALDH1A1 (0.43) | KDM4EALDH1A1CHRNA7MAPTCYP1A2 | |
| SCHEMBL4795994 | 0.78 | TSHR (0.41) | KDM4EALDH1A1CHRNA7CYP1A2 | |
| SCHEMBL12514357 | 0.77 | TAAR1 (0.45) | TAAR1KDM4EALDH1A1PYCR1MAPT | |
| SCHEMBL17166204 | 0.77 | TAAR1 (0.45) | TAAR1KDM4EALDH1A1PYCR1MAPT | |
| SCHEMBL30367150 | 0.77 | TAAR1 (0.45) | TAAR1KDM4EALDH1A1PYCR1MAPT | |
| SCHEMBL14948491 | 0.76 | KCNH2 (0.51) | TAAR1KDM4EALDH1A1CHRNA7HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9944593-B2 | Process for the synthesis of fluoralkyl sulfonate salts | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2018-04-17 | — | — | US | disclosed |
| US-20160237028-A1 | PROCESS FOR THE SYNTHESIS OF FLUORALKYL SULFONATE SALTS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2016-08-18 | — | — | US | disclosed |
| EP-3052474-A1 | PROCESS FOR THE SYNTHESIS OF FLUORALKYL SULFONATE SALTS | Solvay Specialty Polymers Italy S.p.A. (IT) | 2016-08-10 | — | — | EP | disclosed |
| US-9184388-B2 | Layered structure, electronic device using same, aromatic compound, and method for manufacturing said compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-10 | — | — | US | disclosed |
| WO-2015049239-A1 | PROCESS FOR THE SYNTHESIS OF FLUORALKYL SULFONATE SALTS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2015-04-09 | — | — | WO | disclosed |
| US-20130119369-A1 | LAYERED STRUCTURE, ELECTRONIC DEVICE USING SAME, AROMATIC COMPOUND, AND METHOD FOR MANUFACTURING SAID COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237028-A1 | PROCESS FOR THE SYNTHESIS OF FLUORALKYL SULFONATE SALTS | PFAS, SRM, GMPS | TAAR1 1641/4885KDM4E 2503/4885ALDH1A1 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.